Skip to main content

Medtronic Inc(MDT-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low78.74
Day High79.21
Open:79.21
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Motley Fool
Looking for Dividend Growth in the New Year? 3 Magnificent Stocks to Buy Now.
Motley Fool
Medtronic Stock: Bull vs. Bear
MarketBeat
MarketBeat Week in Review – 11/20 - 11/24
Motley Fool
Could Ozempic Harm These 3 Medical Device Stocks?
Motley Fool
Is Medtronic a Good Dividend Stock to Buy Now?
Motley Fool
$1,000 Invested in These 3 Dividend Stocks Could Make You Rich
Motley Fool
If I Could Only Buy 1 Stock Right Now, This Would Be It
Motley Fool
Ignore Crypto: These Stocks Could Make You Rich
MarketBeat
Medtronic: oversold, overextended high yield reversal in play
Motley Fool
Why Medtronic Stock Trounced the Market on Tuesday
Motley Fool
Medtronic (MDT) Q2 2024 Earnings Call Transcript
Motley Fool
Where Will Medtronic Stock Be in 5 Years?
Motley Fool
2 High-Yield Dividend Stocks You Can Buy Now and Hold for a Decade
Motley Fool
3 Brilliant Artificial Intelligence Stocks to Buy and Hold Forever
Newswire.ca
Medtronic to announce financial results for its second quarter of fiscal year 2024
Motley Fool
3 Healthcare Stocks to Buy Hand Over Fist in November
Motley Fool
2 Incredibly Cheap Dividend Stocks to Buy Hand Over Fist Ahead of 2024
Motley Fool
Investing $1,000 in These 2 Top Stocks Would Be a Brilliant Move
Motley Fool
Is a New Bull Market Coming? Here's a Better Question to Ask
AllPennyStocks.com
Microcap Offers Unique Opportunity for Investors In $10 Billion SCI Industry
Motley Fool
2 Beaten-Down Stocks That Haven't Been This Cheap in Over 6 Years
Newswire.ca
OPSENS ANNOUNCES THE POSITIVE CLINICAL RESULTS FROM THE SAFE-TAVI STUDY WITH SAVVYWIRE IN EUROPE
MarketBeat
The Value Deepens for Medtech Stocks: Reversal Imminent
Motley Fool
Intuitive Surgical's Revenue Dipped: Is It Time to Sell?
Newswire.ca
Deep Sky Welcomes Jason Vanderheyden as VP of Government Affairs and Public Policy
Motley Fool
You Can't Control Spin-Offs, but You Can Control What You Do About Them
MarketBeat
Lumentum Lights Up on the AI and ML Surge
Motley Fool
2 Healthcare Dividend Stocks You'd Regret Not Buying on the Dip
Stock Picking, Options Trading for Income
How To Turn An Over Valued Stock Into A Covered Calls And Puts Premiums Winner
Motley Fool
3 Ways AI Can Help Healthcare Companies Grow
Motley Fool
If You'd Invested $10,000 in Medtronic 10 Years Ago, This Is How Much You Would Have Today
MarketBeat
Clorox Pullback Presents a Chance to Clean Up on a 3.6% Dividend

Profile

Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2023.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2023 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.